- Home
- NOMD vs SANA Comparison
NOMD vs SANA Comparison
Compare NOMD & SANA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NOMD | SANA |
|---|---|---|
| Founded | 2014 | 2018 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Packaged Foods | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.4B |
| IPO Year | 2015 | 2021 |
Fundamental Metrics
Financial Performance| Metric | NOMD | SANA |
|---|---|---|
| Price | $9.90 | $3.23 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 5 |
| Target Price | ★ $12.75 | $7.60 |
| AVG Volume (30 Days) | 1.3M | ★ 2.6M |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | ★ 6.91% | N/A |
| EPS Growth | N/A | ★ 17.24 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1.45 | N/A |
| P/E Ratio | $8.38 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.43 | $1.49 |
| 52 Week High | $20.13 | $6.55 |
Technical Indicators
Market Signals| Indicator | NOMD | SANA |
|---|---|---|
| Relative Strength Index (RSI) | 42.98 | 48.50 |
| Support Level | $9.49 | $3.16 |
| Resistance Level | $12.36 | $3.43 |
| Average True Range (ATR) | 0.23 | 0.21 |
| MACD | 0.11 | 0.07 |
| Stochastic Oscillator | 87.72 | 75.33 |
Price Performance
Historical ComparisonAbout NOMD Nomad Foods Limited
Nomad Foods Ltd is a packaged foods company that is involved in the business of manufacturing and distributing branded frozen foods in Western Europe. The company manufactures and markets frozen food products such as fish, vegetables, poultry, Ice Cream, and ready meals like pizza. It sells its products through large grocery retailers under the brand Birds Eye in the United Kingdom and Ireland, Findus in Italy, France, Spain, and Iglo in Germany and other continental markets. The company operates through a single segment being Frozen. The majority of the revenue is generated from the United Kingdom.
About SANA Sana Biotechnology Inc.
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 and others.